Foster City, CA, United States of America

Silas Wang

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silas Wang. Retrieved from https://idiyas.com/inventor/silas-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silas Wang: Innovator in Pharmaceutical Formulations

Introduction

Silas Wang is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating viral infections.

Latest Patents

Silas Wang holds a patent for "Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-L-alaninate." This invention relates to new forms of the compound, pharmaceutical formulations, and their therapeutic uses, especially in treating viral infections such as HIV.

Career Highlights

Silas Wang is currently employed at Gilead Sciences, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for serious viral infections, contributing to advancements in medical science.

Collaborations

Some of his notable coworkers include Olga Viktorovna Lapina and Bing Shi, with whom he collaborates on various projects within the company.

Conclusion

Silas Wang's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has the potential to improve treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…